SCHEMBL2810679

SCHEMBL2810679

O=C1Cc2ccncc2Nc2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 3/20 0.45
CCNB2 O95067 2/20 0.45
CDK1 P06493 2/20 0.45
CCNB1 P14635 2/20 0.45
CDK5 Q00535 2/20 0.45
CDK5R1 Q15078 2/20 0.45
CCNB3 Q8WWL7 2/20 0.45
CCNT1 O60563 1/20 0.45
CCNT2 O60583 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK9 P50750 1/20 0.45
CCNA1 P78396 1/20 0.45
PDGFRA P16234 1/20 0.41
FER P16591 1/20 0.41
LTK P29376 1/20 0.41
CDK8 P49336 1/20 0.41
ACVR1 Q04771 1/20 0.41
LRRK2 Q5S007 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4156077 0.81 AHR (0.59) PDGFRAFERLTKCDK8ACVR1
SCHEMBL1042236 0.81 CYP1A2 (0.48) CDK2CCNB2CDK1CCNB1CDK5
SCHEMBL28939689 0.80 PDE3B (0.38) CDK2CCNB2CDK1CCNB1CDK5
Bromide SCHEMBL28736604 0.78 PDE3B (0.37) CDK2CCNB2CDK1CCNB1CDK5
SCHEMBL21311994 0.77 LRRK2 (0.58) CDK2CCNB2CDK1CCNB1CDK5
SCHEMBL29526300 0.74 PDE3B (0.54) CDK2CCNB2CDK1CCNB1CDK5
SCHEMBL477609 0.74 PDE3B (0.54) CDK2CCNB2CDK1CCNB1CDK5
Hydrochloric Acid SCHEMBL2362200 0.73 PDE3B (0.53) CDK2CCNB2CDK1CCNB1CDK5
SCHEMBL15985206 0.73 NPC1 (0.50) MAPTMAPK1AHRPDK2GAA
SCHEMBL2509785 0.72 ACVR1 (0.69) CDK2CDK5CDK5R1PDGFRAFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8349827-B2 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds ARQULE, INC. (US) 2013-01-08 US disclosed
US-8349827-B2 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds ARQULE, INC. (US) 2013-01-08 US disclosed
US-8349827-B2 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds ARQULE, INC. (US) 2013-01-08 US disclosed
WO-2010114898-A1 SUBSTITUTED DIPYRIDO-PYRIMIDO-DIAZEPINE AND BENZO-PYRIDO-PYRIMIDO COMPOUNDS ARQULE, INC. (US) 2010-10-07 WO disclosed
US-20100249108-A1 SUBSTITUTED DIPYRIDO-PYRIMIDO-DIAZEPINE AND BENZO-PYRIDO-PYRIMIDO COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249108-A1 SUBSTITUTED DIPYRIDO-PYRIMIDO-DIAZEPINE AND BENZO-PYRIDO-PYRIMIDO COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed
US-20100249108-A1 SUBSTITUTED DIPYRIDO-PYRIMIDO-DIAZEPINE AND BENZO-PYRIDO-PYRIMIDO COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249108-A1 SUBSTITUTED DIPYRIDO-PYRIMIDO-DIAZEPINE AND BENZO-PYRIDO-PYRIMIDO COMPOUNDS PDXK, DPYD, DHFR CDK2 61/4885CCNB2 34/4885CDK1 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.